Hanseo Submitted Five International Patent Filings for Its Liver Medication

Published: 2004-12-29 06:54:00

Updated: 2004-12-29 06:54:00

Hanseo Pharm Co. Ltd. recently announced the patent filings of its novel medication HS0406, for the treatment of cirrhosis, to the United States, Japan, China, Russia, and Germany.

Hanseo Pharm, which was newly listed on KOSDAQ in November of this year, expects that HS0406 will be proven effec...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK